Common TitlePEARL-I
Official Title Ombitasvir plus Paritaprevir plus Ritonavir with or without Ribavirin in Treatment-Naive and Treatment-Experienced Patients with Genotype 4 Chronic Hepatitis C Virus Infection (PEARL-I): a Randomised, Open-Label Trial
Phase Phase II
ClinicalTrials.gov NCT01685203
Treatments
Ombitasvir-Paritaprevir-Ritonavir
Ombitasvir-Paritaprevir-Ritonavir
Tradename:TechnivieOther Names:OBV-PTV-RTVClass:DiscontinuedFunding
IndustryAbbVie